
Provention Bio PRVB
Annual report 2022
added 03-29-2023
Provention Bio Total Inventories 2011-2026 | PRVB
Annual Total Inventories Provention Bio
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.23 M | 1.23 M | 1.23 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 320.13 | -3.98 % | $ 41.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.81 | 0.6 % | $ 1.02 B | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.35 | -12.9 % | $ 347 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.26 | 0.47 % | $ 456 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.19 | -1.59 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.61 | 8.05 % | $ 428 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
BioXcel Therapeutics
BTAI
|
722 K | $ 1.07 | 1.9 % | $ 13.1 M | ||
|
ChromaDex Corporation
CDXC
|
14.5 M | - | -0.88 % | $ 598 M |